Asklepios BioPharmaceutical
Durham, US · Delaware corporation
Founders & leadership
SM
Sheila MikhailCEO, Treasurer and Secretary
RS
Richard SamulskiPresident and Chief Science Officer
KW
Katherine WoodNamed on SEC filing
FC
Fred CohenNamed on SEC filing
JG
Javier GarciaNamed on SEC filing
JS
John SchillingNamed on SEC filing
WH
William HawkinsNamed on SEC filing
JS
Jon SalvesonNamed on SEC filing
TF
Timothy FergusonAssistant Secretary
Reported raises · per SEC filings
Form D private placements$199.7M disclosed across 1 round · 2019
▶$199.7MraisedMay 2019 · 33 investors · BiotechnologyRule 506(b)
▶$199.7MraisedMay 2019 · 33 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Katherine WoodDirector
- Fred CohenDirector
- Javier GarciaDirector
- John SchillingDirector
- Timothy FergusonExecutive Officer
- Sheila MikhailExecutive Officer, Director
- Richard SamulskiExecutive Officer, Director
- William HawkinsDirector
- Jon SalvesonDirector
- Offering amount
- $199.7M
- Amount sold
- $199.7M
- Minimum investment
- $101.3K
- Proceeds to insiders
- $190.5K
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Asklepios BioPharmaceutical?
- Asklepios BioPharmaceutical was founded by Sheila Mikhail, Richard Samulski.
- How much funding has Asklepios BioPharmaceutical raised?
- Asklepios BioPharmaceutical has disclosed $199.7M raised across 1 round.
- Where is Asklepios BioPharmaceutical headquartered?
- Asklepios BioPharmaceutical is headquartered in Durham, US.